Association of SARS-CoV-2 cycle threshold (Ct) values with clinical course and serum biomarkers in COVID-19 patients.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 03 2022
Historique:
received: 18 09 2021
accepted: 15 11 2021
entrez: 11 4 2022
pubmed: 12 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

Our knowledge has gaps regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication levels and its association to severity of Coronavirus disease 2019 (COVID-19). The aim of this study was to investigate the association of SARS-CoV-2 viral load with disease severity and serum biomarkers in COVID-19 patients. Viral load was determined via cycle threshold (Ct) values of SARS-CoV-2 real-time reverse transcriptase-polymerase chain reaction (RT-PCR) in 214 adult patients. Ct values were compared with clinical severity, biochemical and hematological biomarkers. Clinical course of the disease was mild (49.1%), moderate (40.2%), and severe (10.7%). Median Ct value was 28.2 (IQR: 22.2-33.8) during the first week of the disease. Ct values were lower within five days after symptom onset [lowest Ct value on the third day (median: 24, IQR: 20.6-32.3)], but they increased significantly during the second and third weeks. No association was detected between admission Ct values and disease severity. Gender, age, co-morbidity, and mortality did not differ significantly in patients with low (≤ 25) and high (> 25) Ct values. White blood cell, neutrophil, platelet, and especially lymphocyte counts, were significantly lower in patients with low Ct values. No definitive/clear correlation between SARS-CoV-2 viral load and severity and mortality was found in the studied COVID-19 patients. However, neutrophil, platelet, and especially lymphocyte count were significantly lower in patients with a high viral load.

Identifiants

pubmed: 35404849
doi: 10.3855/jidc.15818
doi:

Substances chimiques

Biomarkers 0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-452

Informations de copyright

Copyright (c) 2022 Imran Saglik, Beyza Ener, Halis Akalin, Buşra Ozdemir, Gokhan Ocakoglu, Baris Yalcin, Ugur Onal, Ozge Aydin Guçlu, Nilufer Aylin Acet Ozturk, Ulku Tuzemen, Ezgi Demirdogen, Asli Gorek Dilektasli, Harun Agca, Esra Kazak, Funda Coskun, Yasemin Heper, Melda Payaslioglu, Dane Ediger, Ahmet Ursavas, Emel Yilmaz, Cuneyt Ozakin, Esra Uzaslan, Mehmet Karadag.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Imran Saglik (I)

Department of Medical Microbiology, Bursa Uludag University, Bursa, Turkey. imransaglik@gmail.com.

Beyza Ener (B)

Department of Medical Microbiology, Bursa Uludag University, Bursa, Turkey.

Halis Akalin (H)

Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University, Bursa, Turkey.

Buşra Ozdemir (B)

Department of Molecular Biology and Genetics, Canakkale Onsekiz Mart University, Canakkale, Turkey.

Gokhan Ocakoglu (G)

Department of Biostatistics, Bursa Uludag University, Bursa, Turkey.

Baris Yalcin (B)

Microbiology Laboratory of Public Health, Bursa, Turkey.

Ugur Onal (U)

Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University, Bursa, Turkey.

Ozge Aydin Guçlu (O)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Nilufer Aylin Acet Ozturk (NA)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Ulku Tuzemen (U)

Department of Medical Microbiology, Bursa Uludag University, Bursa, Turkey.

Ezgi Demirdogen (E)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Asli Gorek Dilektasli (A)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Harun Agca (H)

Department of Medical Microbiology, Bursa Uludag University, Bursa, Turkey.

Esra Kazak (E)

Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University, Bursa, Turkey.

Funda Coskun (F)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Yasemin Heper (Y)

Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University, Bursa, Turkey.

Melda Payaslioglu (M)

Department of Medical Microbiology, Bursa Uludag University, Bursa, Turkey.

Dane Ediger (D)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Ahmet Ursavas (A)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Emel Yilmaz (E)

Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University, Bursa, Turkey.

Cuneyt Ozakin (C)

Department of Medical Microbiology, Bursa Uludag University, Bursa, Turkey.

Esra Uzaslan (E)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Mehmet Karadag (M)

Department of Chest Diseases, Bursa Uludag University, Bursa, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH